October 19, 2016 - October 22, 2016
Vancouver, BC (Canada)
Thursday, October 20 - 2-3 pm
Genetic variants do not predict efficacy response with mepolizumab in severe asthma.
Lynn Condreay, Genomic Medicine, Scientific Director
Friday, October 21 - 2-3 pm
Pharmacogenetics to inform global drug development: Utilizing data from Western countries to predict PK and Tolerability in Eastern countries
Laura Parham, Genomic Medicine, Associate Scientific Director
Saturday, October 22 -10:45 am
Session 310 Assessment of the genetic basis of rosacea severity by genome-wide association study and expression analysis highlights immuno-inflammation and skin pigmentation as key mechanisms.
Jennifer Aponte, Genomic Medicine, Associate Scientific Director
Visit PAREXEL in the exhibit hall.